Defeat Diabetes has commissioned a clinical research study on how the use of a smartphone app can help patients manage their type 2 diabetes. La Trobe University is investigating the effects of using the Defeat Diabetes app to implement a low carb diet and lifestyle changes to improve glycaemic control over a 12-month period.
The participants are nominated by their GPs, who also monitor their bio-markers over the course of the research period. Below is the case study of research participant Mr D.
Background
- Male 72 years old
- Retired teacher
- Caucasian background
- Type 2 diabetes diagnosed in 2005
- Other medical history: Hypertension, coronary artery disease requiring stenting 2005, renal impairment due to NSAID injury 2016, gastro-oesophageal reflux disease 2021
- Medications: Cartia 100mg daily, Empagliflozin/Metformin 5/500mg one daily, Semaglutide 1mg SC weekly Rosuvastatin 10mg daily, Ezetimide 10mg daily, Telmisartan 40mg daily, Esomeprazole 20mg daily
Started on LCHF diet on 9/2/23 as diabetes was poorly controlled and had not been able to get a supply of semaglutide on a regular basis. Empaglifolazin was ceased on initiation of LCHF diet.
Over the next 6 months, the following medication was de-prescribed on review:
- Telmisartan reduced to 40mg daily and likely to cease on the next review
- Esomeprazole 20mg daily ceased – GORD has resolved
- Ezetimide 10mg daily ceased – cholesterol was well within targets ranges
- Semaglutide 1mg SC weekly- unavailable
Outcome Measure | May 20 2023 | April 4 2023 | July 4 2023 |
|---|---|---|---|
Fasting Blood Glucose mmol/L | 18.4 | 12.4 | 7.2 |
Haemoglobin A1c % | 9.3 | 7.1 | 6.0 |
Total Cholesterol mmol/L | 2.5 | 2.2 | 2.2 |
Trig | 1.6 | - | 1.0 |
GFR | 33 | 42 | 57 |
ALT | 23 | 28 | 26 |
GGT | 31 | 24 | 20 |
BP | 112/69 | 123/67 | 102/78 |
Wt | 80.1 kg | 79 kg | 74.7 kg |
Waist circumference cm | 103 cm | 102 cm | 100 cm |
BMI | 27.6 | 7.2 | 25.7 |
Summarising the main benefits:
- Improved HBA1C
- Improved GFR
- Weight loss
- 4 Medications ceased and money saved!

